Applied Accounts Payable from 2010 to 2024

APLT Stock  USD 8.57  1.64  16.06%   
Applied Therapeutics Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable will likely drop to about 1.7 M in 2024. Accounts Payable is the amount Applied Therapeutics owes to suppliers or vendors for products or services received but not yet paid for. It represents Applied Therapeutics' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2018-12-31
Previous Quarter
2.7 M
Current Value
2.8 M
Quarterly Volatility
2.6 M
 
Covid
Check Applied Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 1.4 M, Interest Income of 1.1 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 22.59, Dividend Yield of 0.0 or Days Sales Outstanding of 8.33. Applied financial statements analysis is a perfect complement when working with Applied Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Applied Therapeutics Correlation against competitors.
For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.

Latest Applied Therapeutics' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Applied Therapeutics over the last few years. An accounting item on the balance sheet that represents Applied Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Applied Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Applied Therapeutics' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Applied Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Applied Accounts Payable Regression Statistics

Arithmetic Mean2,369,593
Geometric Mean1,390,285
Coefficient Of Variation124.83
Mean Deviation2,176,617
Median713,000
Standard Deviation2,958,040
Sample Variance8.7T
Range8.8M
R-Value0.46
Mean Square Error7.4T
R-Squared0.21
Significance0.08
Slope303,955
Total Sum of Squares122.5T

Applied Accounts Payable History

20241.7 M
20231.7 M
20224.5 M
20219.5 M
2020640 K
20198.8 M
2018M

About Applied Therapeutics Financial Statements

Applied Therapeutics shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Applied Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Applied Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Applied Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable1.7 M1.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.